BioNexus Gene Lab Corp (BGLC): EBITDA
Older than the company's other figures. The latest EBITDA is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.
-$234.0K
Year ended 2019-12-31
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2019-12-31 | -$234.0K | n/m | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $100.5K | n/a | 2020-03-31, From 2018-01-01 |